Biotech Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China’s National Reimbursement Drug List November 28, 2024
Biotech New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List November 28, 2024
Biotech Kelun-Biotech’s TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC November 27, 2024
Biotech Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment for Cognitive Impairment Associated with Schizophrenia November 26, 2024
Biotech J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment ‘JIN-001’ – Enhancing Radiation and Chemotherapy Efficacy November 25, 2024
Biotech Novo Holdings to acquire Benchmark Genetics, a leader in aquaculture genetics November 25, 2024
Biotech Global Coalition for Adaptive Research Announces Evaluation of AZD1390 in GBM AGILE Trial November 23, 2024
Biotech Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA November 22, 2024